Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model

Recruiting now

Conditions studied: Inflammatory Bowel Diseases

In brief

TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease. The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.

Key facts

Study ID

NCT06580418

Run by

Inotrem

People needed

40

Starts

2023-01-31

Expected to finish

2025-03-31

Last updated by the study team

2025-02-27

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients between 18 and 60 years
• Signed informed consent
• Ulcerative colitis (UC) patients with active disease
• Crohn's disease (CD) patients with active disease

You may not qualify if…

• UC or CD patients in remission
• Patients between 18 and 60 years without informed consent

Where it is running

• IRCCS San Raffaele — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.